Global IP Protection: Data Exclusivity Is Top USTR Concern As Licensing Recedes

The U.S. Trade Representative's most recent report on global intellectual property rights suggests compulsory licensing may be receding somewhat as a worry for pharmaceutical companies, but inadequate data protection remains a strong concern